Eligi
Med
Ensayos clinicos
Suscripcion
Sobre EligiMed
Ensayos Clinicos de Cardiologia | EligiMed
Ensayos clinicos
796 ensayos encontrados
Completado
ClinicalTrials.gov
Trial Clínico. Utilidad Del Telemonitoreo en Pacientes Con IC Como Medio de Apoyo Para la autogestión de la Enfermedad
INTERVENTIONAL
Inicio: 1 de ago de 2018
ID: NCT04071093
Completado
ClinicalTrials.gov
Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) Project I-A of Imaging Modalities to Assist With Guiding Therapy and the Evaluation of Patients With Heart Failure (IMAGE-HF)
INTERVENTIONAL
Inicio: 1 de ene de 2011
ID: NCT01288560
Completado
ClinicalTrials.gov
An Observational Follow-Up Study Of Patients Previously Enrolled In Exubera Controlled Clinical Trials
OBSERVATIONAL
Inicio: 1 de ago de 2008
ID: NCT00734591
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (2.5 mcg and 5 mcg Once Daily) Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Adolescents (12 to 17 Years Old) With Severe Persistent Asthma
INTERVENTIONAL
Inicio: 1 de ene de 2011
ID: NCT01277523
Completado
Fase 4
ClinicalTrials.gov
A Clinical Evaluation of the XIENCE Everolimus Eluting Coronary Stent System in the Treatment of Women With de Novo Coronary Artery Lesions
INTERVENTIONAL
Inicio: 1 de sept de 2008
ID: NCT01182428
Terminado
Fase 3
ClinicalTrials.gov
A Double-Blind, Active-Controlled, Long-Term Safety Extension Study of Optimized Doses of Darusentan in Subjects With Resistant Hypertension Despite Receiving Combination Therapy With Three or More Antihypertensive Drugs, Including a Diuretic, as Compared to Guanfacine (Protocol DAR-312-E)
INTERVENTIONAL
Inicio: 1 de may de 2007
ID: NCT00389675
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate Cardiovascular Outcomes During Treatment With Lixisenatide in Type 2 Diabetic Patients After an Acute Coronary Syndrome
INTERVENTIONAL
Inicio: 1 de jun de 2010
ID: NCT01147250
Completado
Fase 3
ClinicalTrials.gov
An 8-Month Phase 3, Open-Label Study With a Blinded Reversal Phase to Evaluate the Safety and Tolerability of TAK-491 in Subjects With Essential Hypertension
INTERVENTIONAL
Inicio: 1 de jun de 2007
ID: NCT00696384
Reclutando
Fase 3
ClinicalTrials.gov
CLEOPATTRA: Effects of NNC6019-0001 Versus Placebo on Cardiovascular Outcomes in Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
INTERVENTIONAL
Inicio: 2 de oct de 2025
ID: NCT07207811
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active-Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants With Atrial Fibrillation
INTERVENTIONAL
Inicio: 11 de abr de 2023
ID: NCT05757869
Completado
ClinicalTrials.gov
ABSORB EXTEND Clinical Investigation: A Continuation in the Clinical Evaluation of the ABSORB Bioresorbable Vascular Scaffold (BVS) System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
INTERVENTIONAL
Inicio: 1 de ene de 2010
ID: NCT01023789
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal, Parallel Group Study of Patiromer for the Management of Hyperkalemia in Subjects Receiving Renin Angiotensin Aldosterone System Inhibitor (RAASi) Medications for the Treatment of Heart Failure (DIAMOND)
INTERVENTIONAL
Inicio: 24 de abr de 2019
ID: NCT03888066
Activo, no recluta
ClinicalTrials.gov
NeVa International, MulTi-center, Retrospective cOmparative Stent Retriever Study
OBSERVATIONAL
Inicio: 15 de jun de 2025
ID: NCT06964724
Activo, no recluta
Fase 3
ClinicalTrials.gov
An Open-Label Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term Use of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension
INTERVENTIONAL
Inicio: 7 de mar de 2023
ID: NCT05649748
Por invitacion
Fase 3
ClinicalTrials.gov
A Phase 3 Open-label Extension (OLE) Study to Evaluate the Long-term Safety and Efficacy of Ralinepag in Subjects With World Health Organization (WHO) Group 1 Pulmonary Arterial Hypertension (PAH)
INTERVENTIONAL
Inicio: 23 de sept de 2019
ID: NCT03683186
Activo, no recluta
Fase 3
ClinicalTrials.gov
Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascular Events in Participants at High Cardiovascular Risk
INTERVENTIONAL
Inicio: 9 de oct de 2023
ID: NCT06008756
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multi-Center, Open Label, Safety Study of RSD1235 in Subjects With Atrial Fibrillation
INTERVENTIONAL
Inicio: 1 de oct de 2005
ID: NCT00281554
Completado
Fase 3
ClinicalTrials.gov
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects With Chronic Heart Failure With Reduced Ejection Fraction (GALACTIC-HF)
INTERVENTIONAL
Inicio: 6 de ene de 2017
ID: NCT02929329
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subjects With Type 2 Diabetes Mellitus and Diabetic Nephropathy
INTERVENTIONAL
Inicio: 17 de feb de 2014
ID: NCT02065791
Completado
Fase 3
ClinicalTrials.gov
A PHASE 3B STUDY TO EVALUATE THE POTENTIAL OF ALEGLITAZAR TO REDUCE CARDIOVASCULAR RISK IN PATIENTS WITH STABLE CARDIOVASCULAR DISEASE AND GLUCOSE ABNORMALITIES
INTERVENTIONAL
Inicio: 1 de dic de 2012
ID: NCT01715818
Anterior
1
...
37
38
39
40
Siguiente
Filtros